Steris STE
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Steris (STE) Core Market Data and Business Metrics
Latest Closing Price
$227.57Price-Earnings Ratio
48.21Total Outstanding Shares
98.25 Million SharesDividend
$0.57 Per Share QuarterlySIC Description
Orthopedic, Prosthetic & Surgical Appliances & SuppliesPrimary Exchange
New York Stock ExchangeHeadquarters
70 Sir John Rogerson's Quay, Dublin, L2, 2
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 716,127 Shares | 1.61 | 3/14/2025 | 1,153,284 Shares |
| 424,489 Shares | 2.46 | 2/28/2025 | 1,042,267 Shares |
| 581,214 Shares | 1.6 | 2/14/2025 | 928,683 Shares |
| 476,256 Shares | 2.07 | 1/31/2025 | 985,365 Shares |
| 419,588 Shares | 2.4 | 1/15/2025 | 1,005,272 Shares |
| 524,416 Shares | 2.06 | 12/31/2024 | 1,080,525 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Operating Activities, Continuing | $1.14 Billion |
| Net Cash Flow From Investing Activities | $362.97 Million |
| Net Cash Flow From Financing Activities, Continuing | $-1.54 Billion |
| Exchange Gains/Losses | $-7.42 Million |
| Net Cash Flow, Continuing | $-32.98 Million |
| Net Cash Flow From Investing Activities, Continuing | $362.97 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Diluted Average Shares | $99.20 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $467.59 Million |
| Benefits Costs and Expenses | $4.61 Billion |
| Research and Development | $107.42 Million |
| Operating Income/Loss | $841.07 Million |
| Income Tax Expense/Benefit, Deferred | $-154.69 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $-72.42 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss Attributable To Parent | $-121.62 Million |
| Comprehensive Income/Loss | $422.37 Million |
| Comprehensive Income/Loss Attributable To Parent | $422.37 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Wages | $160.78 Million |
| Intangible Assets | $1.92 Billion |
| Other Current Assets | $1.25 Billion |
| Noncurrent Liabilities | $2.69 Billion |
| Liabilities And Equity | $10.01 Billion |
| Long-term Debt | $2.04 Billion |
Historical Dividends
Current dividend: $0.57 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 28, 2025 | Mar 21, 2025 | Feb 20, 2025 | $0.57 | Quarterly |
| Oct 30, 2024 | Dec 19, 2024 | Nov 19, 2024 | $0.57 | Quarterly |
| Jul 31, 2024 | Sep 20, 2024 | Sep 5, 2024 | $0.57 | Quarterly |
| May 1, 2024 | Jun 26, 2024 | Jun 12, 2024 | $0.52 | Quarterly |
| Jan 30, 2024 | Mar 22, 2024 | Feb 23, 2024 | $0.52 | Quarterly |
| Oct 31, 2023 | Dec 21, 2023 | Nov 21, 2023 | $0.52 | Quarterly |